Letrozole


CAS No. : 112809-51-5

(Synonyms: CGS 20267)

112809-51-5
Price and Availability of CAS No. : 112809-51-5
Size Price Stock
25mg $50 In-stock
50mg $65 In-stock
100mg $79 In-stock
200mg $85 In-stock
500mg $100 In-stock
1g $180 In-stock
5 g Get quote
10 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-14248
M.Wt: 285.30
Formula: C17H11N5
Purity: >98 %
Solubility: DMSO : 50 mg/mL (ultrasonic)
Introduction of 112809-51-5 :

Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-steroidal inhibitor of aromatase, with an IC50 of 11.5 nM. Letrozole selective inhibits estrogen biosynthesis, and can be used for the research of breast cancer[1][2][3]. IC50 & Target:IC50: 11.5 nM (aromatase)[1] In Vitro:Letrozole (0.1-100 nM; 24-96 h) significantly inhibits growth of the MCF-7 epithelial breast cancer cells in a dose- and time-dependent manner[2].
Letrozole (10 nM) significantly suppresses the stimulatory effects of testosterone on MCF-7 cell proliferation[2].
Letrozole (10 nM; 24-48 h) suppresses the levels of secreted metalloproteinases (MMP‐2 and MMP‐9) in MCF-7 cells[2]. In Vivo:Letrozole (3-300 μg/kg; oral gavage once daily for 6 weeks) exhibits anti-tumor effects in rats[3].

Your information is safe with us.